Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENY2 transcription and export complex 2 subunit (ENY2)
- Target
- ENY2
- Molecular classification
- Transcription factor, Chromatin remodeling subunit, Histone modification complex subunit (deubiquitinase module), mRNA export factor/adaptor
01
Overview
ENY2 is a small, evolutionarily conserved protein integral to nuclear gene expression regulation. It serves as a core adaptor subunit in the SAGA/TFTC deubiquitination module, essential for histone H2A and H2B deubiquitination, which counteracts heterochromatin silencing and facilitates nuclear receptor‐dependent transcription. Additionally, ENY2 forms part of the TREX-2 complex regulating mRNA export through nuclear pores. It is recruited to transcribed genes and interacts with various transcription-regulatory, insulator, and export proteins. ENY2's loss or dysfunction can lead to impaired transcription, defective mRNA export, and developmental abnormalities, implicating it in diverse cellular processes and disease states
- Other names
- Sus1DC6Enhancer of yellow 2 transcription factor homologE(Y)2FLJ20480e(y)2
02
Mechanism of action
Drugs targeting associated complexes (e.g., SAGA, USP22) potentially modulate ENY2-linked transcriptional activation by: - Inhibiting histone deubiquitination - Affecting chromatin accessibility - Modulating mRNA processing/export
03
Biological functions
Transcription regulation (coactivator activities for nuclear receptors and RNA polymerase II-dependent transcription)Chromatin remodeling (histone H2A and H2B deubiquitination)mRNA export (poly(A)+ mRNA export from nucleus through nuclear pore complexes)Formation of mRNP (messenger ribonucleoprotein) complexesInsulator and barrier activity within the genome
04
Disease associations
Cancer (by influencing cell proliferation and tumor growth via chromatin modification)Spinocerebellar ataxia 7 (genetic associations)Arthrogryposis, distal, type 6 (genetic associations)
05
Safety considerations
As an essential adaptor in gene expression, modulation of ENY2 or its complexes can lead to broad effects on transcription, chromatin integrity, cell viability, and developmental processes, presenting therapeutic challenges
06
Biomarkers
ENY2 expression or activity may correlate with cell proliferation, tumor growth, or specific genetic diseases but is not established as a routine biomarker in clinical practice
Beyond the preview
Go deeper on ENY2 transcription and export complex 2 subunit (ENY2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ENY2 transcription and export complex 2 subunit (ENY2).